The Company has significant player in the Cardiovascular Diabetology Asthma Pediatric Central Nervous System (CNS) Gastro-Intestinal (GI) Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) ...

Lupin Ltd share price was down by -1.17% from the previous closing price of ₹2,056.25. Who are peers of Lupin Ltd? The peers of Lupin Ltd are Sun Pharmaceuticals Industries Ltd, Divis ...

Global pharma major Lupin Limited (Lupin) and its alliance partner Natco Pharma Limited (Natco), announced that they have received an approval from the United States Food and Drug Administration (FDA) ...

Here are some of the stocks that may see significant price movement today: Tata Motors, BHEL, Hindalco, Lupin, etc.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Drug firm Lupin Ltd on Monday (February 10) said it has received approval from the United States Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for ipratropium ...

The Quarterly Results page of Lupin Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results.

Lupin and Natco Receive Approval from U. S. FDA for Bosentan Tablets for Oral Suspension.

Lupin Receives Approval from U. S. FDA for Ipratropium Bromide Nasal Solution (NASAL Spray), 0.03% ...